These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8740993)

  • 1. Biological markers and diagnostic investigations in Alzheimer's disease.
    Wahlund LO
    Acta Neurol Scand Suppl; 1996; 165():85-91. PubMed ID: 8740993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and genetic markers of sporadic Alzheimer's disease.
    Engelborghs S; De Deyn PP
    Acta Med Okayama; 2001 Apr; 55(2):55-63. PubMed ID: 11332200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
    Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
    N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of biological markers in the early and differential diagnosis of Alzheimer's disease.
    Kurz A; Riemenschneider M; Drzezga A; Lautenschlager N
    J Neural Transm Suppl; 2002; (62):127-33. PubMed ID: 12456058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's and related diseases: toward earlier and more accurate diagnosis].
    Fortin MP; Krolak-Salmon P
    Rev Med Interne; 2010 Dec; 31(12):846-53. PubMed ID: 20952104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Markers of prodromal Alzheimer's disease].
    de Souza LC; Sarazin M; Uspenskaya O; Habert MO; Lamari F; Lehéricy S; Dubois B
    Rev Neurol (Paris); 2012 Nov; 168(11):815-24. PubMed ID: 22944619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of MRI and PET/SPECT in Alzheimer's disease.
    Coimbra A; Williams DS; Hostetler ED
    Curr Top Med Chem; 2006; 6(6):629-47. PubMed ID: 16712496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts.
    Schmand B; Eikelenboom P; van Gool WA;
    J Am Geriatr Soc; 2011 Sep; 59(9):1705-10. PubMed ID: 21883100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-β.
    Maya Y; Okumura Y; Kobayashi R; Onishi T; Shoyama Y; Barret O; Alagille D; Jennings D; Marek K; Seibyl J; Tamagnan G; Tanaka A; Shirakami Y
    Brain; 2016 Jan; 139(Pt 1):193-203. PubMed ID: 26490333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for Alzheimer's disease.
    Pauwels EK; Volterrani D; Mariani G
    Drug News Perspect; 2009 Apr; 22(3):151-60. PubMed ID: 19440558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
    Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
    Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of Alzheimer's disease: the present and the future.
    Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A
    Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.